Day: August 17, 2021

Figure 1Drill results from Golden Sky’s maiden reverse-circulation drill program at the Sure Bet ZoneFigure 2The Hotspot property has been significantly expanded by staking during the 2021 exploration seasonFigure 3The Hotspot property is located within one of the most prolific districts for major gold discoveriesFigure 4Soil geochemistry overlying a ground magnetic surveyVANCOUVER, British Columbia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Golden Sky Minerals Corp. (AUEN.V) (the “Company” or “Golden Sky”) is pleased to announce that it has mobilized to its 100% owned Hotspot property (“Property”) for its inaugural ~1500m diamond drill program that will commence in mid-August 2021. Diamond drilling will further test the Sure Bet Zone, which is defined by a ~600m x 400m...

New York, NY, and Tel Aviv, ISRAEL, Aug. 17, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Todos Medical will be presenting at the upcoming Emerging Growth Conference to be held on August 18, 2021. The following are details for the conferences: Event: Emerging Growth Conference Date: August 18, 2021 Location: On-Line Time: Todos Medical Presentation at 12:00pm Todos Medical will be presenting at the upcoming Emerging Growth Conference being held on August 18, 2021. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s CEO, Gerald Commissiong in real time. Please register here to ensure you are able to attend the conference...

TORONTO and KNOXVILLE, Tenn., Aug. 17, 2021 (GLOBE NEWSWIRE) — Solar Alliance Energy Inc. (‘Solar Alliance’ or the ‘Company’) (TSX-V: SOLR) is pleased to announce that CEO Myke Clark will present at the Sidoti Microcap Virtual Investor Conference Wednesday August 18, 2021 at 9:15 AM-9:45 AM ET The presentation can be accessed live at this link. Mr. Clark will also conduct one-on-one meetings with investors during the two-day conference. “Solar Alliance is pleased to be presenting at the Sidoti August Microcap Virtual Investor Conference and bringing our compelling investment opportunity to a broader audience,” said CEO Myke Clark. “This year has been a transformative year for Solar Alliance as we have signed agreements for two construction ready solar projects that we will own and operate, expanded the size and scale of commercial...

GREENWICH, Conn. , Aug. 17, 2021 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO), the world’s largest pure-play contract logistics provider, today released findings from its most recent global survey on trends in e-commerce and returns. The survey details trends in consumer shopping habits and retailer behaviors, including the link between increased e-commerce activity and higher returns volumes. Key takeaways from the survey include:72% of retailers are investing in their returns management processes. More than a quarter of retailers recently invested in additional warehouse space. 57% of consumers say having a sustainable returns program is an important factor when making a purchase online. In the past 12 months:36% of retailers say online returns have increased.  37% of retailers said returns have increased their operational...

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2021 (GLOBE NEWSWIRE) — Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for patients of all ages with genomically defined cancers, today announced the appointment of Scott Garland to the Company’s board of directors. Mr. Garland is a 30-year veteran of the biopharmaceutical industry with deep commercial and executive leadership experience. “We are very pleased to welcome Scott to our board of directors at this important stage in Day One’s evolution,” said Jeremy Bender, Ph.D., chief executive officer of Day One. “Having led the launch of multiple new medicines, Scott’s commercial expertise will be invaluable as we advance our pivotal Phase 2 FIREFLY-1 clinical trial of DAY101 in pediatric patients...